GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Galectin Therapeutics Inc (FRA:PHPN) » Definitions » FCF Yield %

Galectin Therapeutics (FRA:PHPN) FCF Yield % : -15.44 (As of Apr. 29, 2024)


View and export this data going back to 2007. Start your Free Trial

What is Galectin Therapeutics FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Galectin Therapeutics's Trailing 12-Month Free Cash Flow is €-30.63 Mil, and Market Cap is €199.08 Mil. Therefore, Galectin Therapeutics's FCF Yield % for today is -15.44%.

The historical rank and industry rank for Galectin Therapeutics's FCF Yield % or its related term are showing as below:

FRA:PHPN' s FCF Yield % Range Over the Past 10 Years
Min: -37.68   Med: 0   Max: 0
Current: -15.44


FRA:PHPN's FCF Yield % is ranked better than
50.16% of 1549 companies
in the Biotechnology industry
Industry Median: -15.5 vs FRA:PHPN: -15.44

Galectin Therapeutics's FCF Margin % for the quarter that ended in Dec. 2023 was 0.00%.


Galectin Therapeutics FCF Yield % Historical Data

The historical data trend for Galectin Therapeutics's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Galectin Therapeutics FCF Yield % Chart

Galectin Therapeutics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
FCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -6.76 -16.30 -19.18 -46.54 -33.71

Galectin Therapeutics Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -43.40 -35.62 -48.36 -26.75 -19.23

Competitive Comparison of Galectin Therapeutics's FCF Yield %

For the Biotechnology subindustry, Galectin Therapeutics's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Galectin Therapeutics's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Galectin Therapeutics's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Galectin Therapeutics's FCF Yield % falls into.



Galectin Therapeutics FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Galectin Therapeutics's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-30.229 / 89.686705
=-33.71%

Galectin Therapeutics's annualized FCF Yield % for the quarter that ended in Dec. 2023 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-4.312 * 4 / 89.686705
=-19.23%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Galectin Therapeutics FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Galectin Therapeutics FCF Yield % Related Terms

Thank you for viewing the detailed overview of Galectin Therapeutics's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Galectin Therapeutics (FRA:PHPN) Business Description

Traded in Other Exchanges
Address
4960 Peachtree Industrial Boulevard, Suite 240, Norcross, GA, USA, 30071
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its lead galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.

Galectin Therapeutics (FRA:PHPN) Headlines

No Headlines